Palliative care for heart failure : Time to move beyond treating and curing to improving the end of life

Por Stewart, Simon, McMurray, John J V
Publicado em 2002

The neprilysin pathway in heart failure: a review and guide on the use of sacubitril/valsartan

Por Jhund, Pardeep S, McMurray, John J V
Publicado no Heart (2016)

Effect of aspirin on vasodilation to bradykinin and substance P in patients with heart failure treated with ACE inhibitor

Por Davie, Andrew P, McMurray, John J V
Publicado em 2002

SOLOIST‐WHF and updated meta‐analysis: sodium–glucose co‐transporter 2 inhibitors should be initiated in patients hospitalized with worsening heart failure

Por Docherty, Kieran F., McMurray, John J.V.
Publicado no Eur J Heart Fail (2020)

The acute vascular effects of frusemide in heart failure

Por Jhund, Pardeep S, McMurray, John J V, Davie, Andrew P
Publicado em 2000

Who Benefits From a Defibrillator—Balancing the Risk of Sudden Versus Non-sudden Death

Por Beggs, Simon A. S., Gardner, Roy S., McMurray, John J. V.
Publicado no Curr Heart Fail Rep (2018)

Sacubitril/Valsartan in Asian Patients with Heart Failure with Reduced Ejection Fraction

Por Dewan, Pooja, Docherty, Kieran F., McMurray, John J.V.
Publicado no Korean Circ J (2019)

Talking to patients with heart failure about end of life

Por Campbell, Ross T., Petrie, Mark C., McMurray, John J.V.
Publicado no Eur J Heart Fail (2018)

Lung ultrasound: monitoring congestion in patients with heart failure

Por Platz, Elke, Solomon, Scott D., McMurray, John J.V.
Publicado no Eur J Heart Fail (2019)

Do patients with suspected heart failure and preserved left ventricular systolic function suffer from “diastolic heart failure” or from misdiagnosis? A prospective descriptive stud...

Por Caruana, Lynn, Petrie, Mark C, Davie, Andrew P, McMurray, John J V
Publicado em 2000

The Dapagliflozin and Prevention of Adverse outcomes in Heart Failure trial (DAPA-HF) in context

Por McMurray, John J V, Solomon, Scott D, Docherty, Kieran F, Jhund, Pardeep S
Publicado no Eur Heart J (2020)

Terminology and definition of changes renal function in heart failure

Por Damman, Kevin, Tang, W.H. Wilson, Testani, Jeffrey M., McMurray, John J.V.
Publicado no Eur Heart J (2014)

What can we learn from RELAX-AHF compared to previous AHF trials and what does the future hold?

Por Cannon, Jane A, McKean, Andrew R, Jhund, Pardeep S, McMurray, John J V
Publicado no Open Heart (2015)

Personalized medicine and hospitalization for heart failure: if we understand it, we may be successful in treating it

Por Ahmad, Faheem A., Petrie, Mark C., McMurray, John J.V., Lang, Ninian N.
Publicado no Eur J Heart Fail (2019)

Statins in the Prevention and Treatment of Heart Failure: a Review of the Evidence

Por Lee, Matthew M. Y., Sattar, Naveed, McMurray, John J. V., Packard, Chris J.
Publicado no Curr Atheroscler Rep (2019)

Association is not causation: treatment effects cannot be estimated from observational data in heart failure

Por Rush, Christopher J, Campbell, Ross T, Jhund, Pardeep S, Petrie, Mark C, McMurray, John J V
Publicado no Eur Heart J (2018)

The year in cardiology: heart failure: The year in cardiology 2019

Por Cleland, John G F, Lyon, Alexander R, McDonagh, Theresa, McMurray, John J V
Publicado no Eur Heart J (2020)

Cohort study of plasma natriuretic peptides for identifying left ventricular systolic dysfunction in primary care

Por McClure, Samuel J, Caruana, Lynn, Davie, Andrew P, Goldthorp, Steven, McMurray, John J V
Publicado em 1998

Aliskiren, ALTITUDE, and the implications for ATMOSPHERE

Por McMurray, John J.V., Abraham, William T., Dickstein, Kenneth, Køber, Lars, Massie, Barry M., Krum, Henry
Publicado em 2012

Effects of adrenomedullin on angiotensin II stimulated atrial natriuretic peptide and arginine vasopressin secretion in healthy humans

Por Petrie, Mark C, McDonald, John E, Hillier, Chris, Morton, James J, McMurray, John J V
Publicado em 2001